(IN BRIEF) At the CTAD 2024 congress in Madrid, Roche presented new data on its Elecsys® Amyloid Plasma Panel and Elecsys ptau181, demonstrating their effectiveness in diagnosing Alzheimer’s disease. The blood-based test showed a negative predictive value of 96.2% in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Media, News, Pharma & Biotech, Science, Spain, Switzerland, Technology
Tagged Alzheimer, Clinical Trials in Alzheimer’s Disease congress (CTAD) 2024, diagnostics, Elecsys ptau181, Elecsys® Amyloid Plasma Panel, Healthcare, Matt Sause, Roche, Spain
The company announces FDA clearance for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad access to high quality testing in a timely … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Alzheimer, beta-amyloid, biomarkers t, CT scan, diagnosis, Elecsys AD CSF Abeta42, Elecsys AD CSF assays, FDA, MRI, pTau181 assays, Roche, tau proteins, Thomas Schinecker
La compañía anuncia la aprobación de la FDA para sus ensayos de líquido cefalorraquídeo (LCR) para la enfermedad de Alzheimer Los ensayos Elecsys® para la enfermedad de Alzheimer (EA) en LCR estarán disponibles en los analizadores de inmunoensayo totalmente automatizados … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Alzheimer, beta-amiloide, biomarcadores t, Diagnóstico, Elecsys AD CSF Abeta42, Elecsys Ensayos AD LCR, Elecsys® beta-amiloide, Elecsys® Phospho-Tau, FDA, patología de Alzheimer, proteínas tau, pTau181 ensayos, resonancia magnética, Roche, Thomas Schinecker, tomografía computarizada
(PRESS RELEASE) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, the Swiss research institute for applied materials sciences and technology, has announced that its researchers in collaboration with clinical partners (Cantonal Hospital and the Geriatric Clinic in St. Gallen) are working on … Read the full press release
Posted in Healthcare, News, Science, Switzerland, Technology
Tagged Alzheimer, Alzheimers disease, cognitive motor fitness games, confusion, dementias, diagnosis, Dividat AG, Empa, ETH Zurich, exergames, Forgetfulness, Kerstin Kündig, Michael Bürgisser, mild brain disorders, mild cognitive impairment, neurodegenerative, neuropsychological tests, Patrick Eggenberger, researchers, sensor belt, Simon Annaheim
(COMUNICADO DE PRENSA) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, el instituto de investigación suizo de ciencia y tecnología de materiales aplicados, ha anunciado que sus investigadores, en colaboración con socios clínicos (Cantonal Hospital y la Clínica Geriátrica de St. Gallen) … Read the full press release
Posted in Healthcare, Science, Switzerland, Technology
Tagged Alzheimer, cinturón sensor, confusión, demencias, deterioro cognitivo leve, Diagnóstico, Dividat AG, Empa, enfermedad de Alzheimer, ETH Zurich, exergames, investigadores, juegos de acondicionamiento motor cognitivo, Kerstin Kündig, Michael Bürgisser, neurodegenerativo, Olvido, Patrick Eggenberger, pruebas neuropsicológicas, Simon Annaheim, trastornos cerebrales leves
(PRESS RELEASE) HELSINKI, 27-Dec-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland, and University Hospital Helsinki, Finland’s largest provider of healthcare services, have announced a new study that investigates the connection between … Read the full press release
Posted in Education, Finland, Healthcare, News, Science, Technology
Tagged Acta Neuropathologica Communications, Alzheimer, Alzheimer’s disease, APOE4 allele, cerebral microhaemorrhages, FinnGen project, genetic homogeneity, Helsinki University Hospital, Johanna Hästbacka, Liisa Myllykangas, memory disorders, mental fatigue, RESEARCH, study, University of Helsinki, ε4 allele
(PRESS RELEASE) MUNICH, 09-Jan-2019 — /EuropaWire/ — Defects in the geneTREM2 are linked to increased risk of Alzheimer’s disease. The gene is required to activate immune cells called microglia in the brain, which help to eliminate the neurotoxic deposits that are … Read the full press release
Posted in Education, Germany, Healthcare, Science, Technology
Tagged Alzheimer, Alzheimer's, amyloid plaques, Christian Haass, dementia, disease, geneTREM2, microglia, Neurobiology, RESEARCH
GENEVA, 08-Jun-2016 — /EuropaWire/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy (no medication, no surgery) coming from the United States helps patients suffering from migraines, concussions, strokes, AD/HD, Parkinson disease, Alzheimer, … Read the full press release
Posted in Education, Germany, Healthcare, Netherlands, News, Sports, Switzerland, United Kingdom
Tagged ADHD, Alzheimer, central nervous system, Concussions, dizziness, headaches, migraines, Mr. Claude Martinet, Parkinson, stroke, Switzerland, TESTmyBRAIN, testmybrain.ch
LIVERPOOL, 4-8-2015 — /EuropaWire/ — Scientists at the University of Liverpool have, for the first time, characterised a genetic mutation that can increase the risk of two major degenerative diseases, age-related macular degeneration (AMD) and Alzheimer’s disease. AMD and Alzheimer’s … Read the full press release
SOUTHAMPTON, 16-12-2014 — /EuropaWire/ — Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current approaches in Alzheimer’s trials be failing? The new study is published in the Journal of Pathology and funded by Alzheimer’s … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged Alzheimer, dementia research, Dr Delphine Boche, Dr Laura Phipps, University of Southampton
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
